Literature DB >> 20667578

MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunction.

Anne Nolting1, Anne-Sophie Dugast, Suzannah Rihn, Rutger Luteijn, Mary F Carrington, Katherine Kane, Stephanie Jost, Ildiko Toth, Ellen Nagami, Gerd Faetkenheuer, Pia Hartmann, Marcus Altfeld, Galit Alter.   

Abstract

Natural killer (NK) cells play a critical role in host defense against viral infections. However chronic HIV-1 infection is associated with an accumulation of dysfunctional NK cells, that poorly control viral replication. The underlying mechanisms for this NK cell mediated dysfunction are not understood. Certain tumors evade NK cell mediated detection by dampening NK cell activity through the downregulation of NKG2D, via the release of soluble NKG2D-ligands, resulting in a potent suppression of NK cell function. Here we show that chronic HIV-1 infection is associated with a specific defect in NKG2D-mediated NK cell activation, due to reduced expression and transcription of NKG2D. Reduced NKG2D expression was associated with elevated levels of the soluble form of the NKG2D-ligand, MICA, in patient sera, likely released by HIV+CD4+ T cells. Thus, like tumors, HIV-1 may indirectly suppress NK cell recognition of HIV-1-infected CD4+ T cells by enhancing NKG2D-ligand secretion into the serum resulting in a profound impairment of NK cell function.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20667578      PMCID: PMC2932841          DOI: 10.1016/j.virol.2010.05.014

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  46 in total

1.  Ongoing trials with matrix metalloproteinase inhibitors.

Authors:  P D Brown
Journal:  Expert Opin Investig Drugs       Date:  2000-09       Impact factor: 6.206

2.  A renaissance for the tumor immunosurveillance hypothesis.

Authors:  L L Lanier
Journal:  Nat Med       Date:  2001-11       Impact factor: 53.440

3.  KIR expression on self-reactive CD8+ T cells is controlled by T-cell receptor engagement.

Authors:  B Huard; L Karlsson
Journal:  Nature       Date:  2000-01-20       Impact factor: 49.962

4.  Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02).

Authors:  Sophie Limou; Sigrid Le Clerc; Cédric Coulonges; Wassila Carpentier; Christian Dina; Olivier Delaneau; Taoufik Labib; Lieng Taing; Rob Sladek; Christiane Deveau; Rojo Ratsimandresy; Matthieu Montes; Jean-Louis Spadoni; Jean-Daniel Lelièvre; Yves Lévy; Amu Therwath; François Schächter; Fumihiko Matsuda; Ivo Gut; Philippe Froguel; Jean-François Delfraissy; Serge Hercberg; Jean-François Zagury
Journal:  J Infect Dis       Date:  2009-02-01       Impact factor: 5.226

5.  Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity.

Authors:  A Diefenbach; E R Jensen; A M Jamieson; D H Raulet
Journal:  Nature       Date:  2001-09-13       Impact factor: 49.962

6.  Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells.

Authors:  V Groh; R Rhinehart; J Randolph-Habecker; M S Topp; S R Riddell; T Spies
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

7.  Tumor-associated MICA is shed by ADAM proteases.

Authors:  Inja Waldhauer; Dennis Goehlsdorf; Friederike Gieseke; Toni Weinschenk; Mareike Wittenbrink; Andreas Ludwig; Stefan Stevanovic; Hans-Georg Rammensee; Alexander Steinle
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

8.  Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands.

Authors:  Brett K Kaiser; Daesong Yim; I-Ting Chow; Segundo Gonzalez; Zhenpeng Dai; Henning H Mann; Roland K Strong; Veronika Groh; Thomas Spies
Journal:  Nature       Date:  2007-05-09       Impact factor: 49.962

9.  Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis.

Authors:  Kui Li; Masaki Mandai; Junzo Hamanishi; Noriomi Matsumura; Ayako Suzuki; Haruhiko Yagi; Ken Yamaguchi; Tsukasa Baba; Shingo Fujii; Ikuo Konishi
Journal:  Cancer Immunol Immunother       Date:  2008-09-13       Impact factor: 6.968

10.  Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection.

Authors:  Qingquan Liu; Yongtao Sun; Suzannah Rihn; Anne Nolting; Peter Nicholas Tsoukas; Stephanie Jost; Kristen Cohen; Bruce Walker; Galit Alter
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

View more
  19 in total

1.  The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR.

Authors:  Giulia Matusali; Marina Potestà; Angela Santoni; Cristina Cerboni; Margherita Doria
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

Review 2.  Microenvironment abnormalities and lymphomagenesis: Immunological aspects.

Authors:  Joseph G Taylor; John G Gribben
Journal:  Semin Cancer Biol       Date:  2015-07-29       Impact factor: 15.707

3.  Damage control: how HIV survives the editor APOBEC3G.

Authors:  J Ludovic Croxford; Stephan Gasser
Journal:  Nat Immunol       Date:  2011-09-20       Impact factor: 25.606

4.  Exploring the potential of monoclonal antibody therapeutics for HIV-1 eradication.

Authors:  Zelda Euler; Galit Alter
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

Review 5.  Evasion from NK cell-mediated immune responses by HIV-1.

Authors:  Stephanie Jost; Marcus Altfeld
Journal:  Microbes Infect       Date:  2012-05-21       Impact factor: 2.700

6.  Acquisition of activation receptor ligand by trogocytosis renders NK cells hyporesponsive.

Authors:  Cathrine A Miner; Tusar K Giri; Claire E Meyer; Mark Shabsovich; Sandeep K Tripathy
Journal:  J Immunol       Date:  2015-01-12       Impact factor: 5.422

Review 7.  Optimizing intracellular signaling domains for CAR NK cells in HIV immunotherapy: a comprehensive review.

Authors:  Giorgio Zenere; Omalla Allan Olwenyi; Siddappa N Byrareddy; Stephen E Braun
Journal:  Drug Discov Today       Date:  2019-02-13       Impact factor: 7.851

Review 8.  Natural killer cells in HIV-1 infection and therapy.

Authors:  Joanna Mikulak; Ferdinando Oriolo; Elisa Zaghi; Clara Di Vito; Domenico Mavilio
Journal:  AIDS       Date:  2017-11-13       Impact factor: 4.177

9.  The natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppression.

Authors:  Stephanie M Dillon; Eric J Lee; Julia M Bramante; Edward Barker; Cara C Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2014-03-01       Impact factor: 3.731

10.  Genome-wide association study on the development of cross-reactive neutralizing antibodies in HIV-1 infected individuals.

Authors:  Zelda Euler; Marit J van Gils; Brigitte D Boeser-Nunnink; Hanneke Schuitemaker; Daniëlle van Manen
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.